Bacterial outer membrane vesicles: Potential and applications in next-generation vaccines

Area of Science:

• Biotechnology
• Immunology
• Microbiology

Background:

• Outer membrane vesicles (OMVs) are released by Gram-negative bacteria and mimic bacterial cell structures.
• OMVs play roles in bacterial pathophysiology and host interactions.
• Their composition includes immunogenic factors and pathogen-associated molecular patterns.

Purpose of the Study:

• To discuss the structural and functional aspects of OMVs.
• To highlight the innovative potential of OMVs as vaccine platforms.
• To address technological challenges in OMV development and scale-up.

Main Methods:

• Review of existing literature on OMV structure, function, and applications.
• Analysis of preclinical trial data for OMV-based vaccines.
• Discussion of bioengineering strategies for OMV vaccine development.

Main Results:

• OMVs offer advantages over traditional vaccines, including T cell-mediated immunity and inherent adjuvant effects.
• Bioengineering allows OMVs to display heterologous antigens for targeted immune responses.
• Preclinical trials demonstrate effective protection against infections using OMV platforms.

Conclusions:

• OMVs represent a versatile and safe platform for next-generation vaccines, including for emerging diseases and cancer immunotherapy.
• Their stability, lack of replicative capacity, and ease of production are key advantages.
• Standardization, purification, and industrial scale-up are key challenges for widespread OMV vaccine implementation.